Diets Premium
Revinty Ellipta-H-C-2745-A31-14165: EPAR - Assessment Report - Article 31
1 / 1
1 view
Download
Pharmaceutical

Revinty Ellipta-H-C-2745-A31-14165: EPAR - Assessment Report - Article 31

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

-

Strength

-

Pack Size

-

Form

-

Source

European Medicines Agency

View Source

Related Clinical Articles

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

View All Alternatives

Related Medications

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class
View All Alternatives